Cogent Biosciences News

Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Celldex (CLDX) and Laboratory (LH)

TipRanksFeb 27 23:40 ET

Cogent Biosciences Analyst Ratings

BenzingaFeb 27 12:58 ET

Analysts Offer Insights on Healthcare Companies: Cigna (CI), Cogent Biosciences (COGT) and Canopy Growth (CGC)

TipRanksFeb 27 07:30 ET

Cogent Biosciences Analyst Ratings

BenzingaFeb 26 11:44 ET

Cogent Downgraded at Baird on Rare Disease Drug Data

Seeking AlphaFeb 26 11:17 ET

Cogent Biosciences Analyst Ratings

BenzingaFeb 26 04:58 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cogent Biosciences (COGT) and Moderna (MRNA)

TipRanksFeb 26 04:40 ET

Analysts Offer Insights on Healthcare Companies: Cogent Biosciences (COGT), Lantheus (LNTH) and Ardelyx (ARDX)

TipRanksFeb 23 08:40 ET

Cogent Biosciences Analyst Ratings

BenzingaFeb 23 08:13 ET

Analysts' Top Healthcare Picks: BioMarin Pharmaceutical (BMRN), Cogent Biosciences (COGT)

TipRanksFeb 23 07:11 ET

Buy Rating Affirmed for Cogent Biosciences as Bezuclastinib Showcases Strong Market Potential

TipRanksFeb 23 06:06 ET

Buy Rating Affirmed on Cogent Biosciences Amid Positive Outlook for Bezuclastinib's Efficacy and Safety

TipRanksFeb 22 00:17 ET

Buy Rating Affirmed for Cogent Biosciences Ahead of Key Data Presentation on Bezuclastinib With Strong Upside Potential

TipRanksFeb 15 01:17 ET

Analysts Offer Insights on Healthcare Companies: Elevance Health (ELV) and Cogent Biosciences (COGT)

TipRanksFeb 14 18:52 ET

Cogent Biosciences Analyst Ratings

BenzingaFeb 12 06:30 ET

Cogent Biosciences: A Balanced Buy Rating Ahead of Key Data Release

TipRanksFeb 12 05:25 ET

Citi Initiates Coverage of Cogent at Buy, Sees Bezuclastinib Potential

InvestingFeb 8 09:35 ET

Cogent Biosciences Analyst Ratings

BenzingaFeb 8 07:35 ET

Buy Rating on Cogent Biosciences Amid Market Overreaction and Promising Drug Prospects

TipRanksFeb 8 05:07 ET

Cogent Biosciences Analyst Ratings

BenzingaDec 15, 2023 06:33 ET